Get notified of page updates

Using the Drug eRapa to Prevent the Growth of Polyps in People with Familial Adenomatous Polyposis (SERENTA)

Prevention

Prevention study for people with Familial Adenomatous Polyposis (FAP) who have polyps in the colon or rectum

Clinicaltrials.gov identifier:
NCT06950385

Study Contact Information:

Name: Amy Ellenberger
Phone Number: 210-346-8330
Email: aellenberger@lumabridge.com

PRINTER FRIENDLY PAGE
Glossary on
off

About the Study

This study is a Phase 3 clinical trial known as SERENTA. The purpose of this trial is to find out if a medication called eRapa can help people with Familial Adenomatous Polyposis (FAP) who are at high risk of disease progression. 

This Study is Open To:

People 18 years or older with FAP can participate if they have any one of the following:

  • more than 100 but less than 501  in the colon, or
  • 10 or more in the retained rectum/sigmoid or ileal pouch that are 3 mm or larger, or
  • Spigelman 3 or 4 with at least 1 polyp that is 10 mm or larger to be removed at baseline or on endoscopy performed within 18 months of screening.

This Study is NOT Open To:

People cannot participate if they:

  • have high-grade dysplasia or cancer within the duodenum, colon, rectum, or ileal pouch that has not be completely removed at the time of screening endoscopy.
  • have had surgery within 6 weeks of starting on the study.
  • have an active cancer or a cancer diagnosis within 2 years before starting on the study. 
  • have any active infection or medical condition that might affect participation in the study. 

People will be assigned at random to one of two groups. 

Group One: 

  • Take the study drug eRapa by mouth every other week until the disease gets worse.
  • Have checkups and tests every 3 months.
  • Have an endoscopy at the start of the study and then every 6 months to check on whether the disease is getting better or worse.

Group Two:

  • Take a by mouth every other week until the disease gets worse. 
  •  Have checkups and tests every 3 months.
  • Have an endoscopy at the start of the study and then every 6 months to check on whether the disease is getting better or worse.

Find more information and study locations here

Study Contact Information:

Name: Amy Ellenberger
Phone Number: 210-346-8330
Email: aellenberger@lumabridge.com

Connecticut

City: New Haven RECRUITING
Facility: Yale Cancer Center
Contact Info:
edgar.benitez@yale.edu 2033936591

District of Columbia

City: Washington D.C. RECRUITING
Facility: Georgetown University
Contact Info:
priyanka.kanth@medstar.net 202-444-1431

Florida

City: Orlando RECRUITING
Facility: Digestive & Liver Center of Florida
Contact Info:
alisa.delvecchio@dlcfl.com 407-490-4526

City: Weston RECRUITING
Facility: Cleveland Clinic Florida
Contact Info:
nicolam4@ccf.org 954-659-6213

Kansas

City: Kansas City RECRUITING
Facility: University of Kansas Medical Center
Contact Info:
labella@kumc.edu 913-584-0533

Maryland

City: Baltimore RECRUITING
Facility: Johns Hopkins University
Contact Info:
erapastudy@live.johnshopkins.edu 410-614-1982

Michigan

City: Ann Arbor RECRUITING
Facility: University of Michigan
Contact Info:
eskoeppe@med.umich.edu 734-998-1274

Missouri

City: St Louis RECRUITING
Facility: Department of Surgery, Section of Colon Rectal and Surgery
Contact Info:
asimabadic@wustl.edu 314- 362-2646

Ohio

City: Cleveland RECRUITING
Facility: Cleveland Clinic
Contact Info:
Reardol3@ccf.org (216) 444-7493

City: Columbus RECRUITING
Facility: Ohio State University
Contact Info:
kebire.gofar@osumc.edu 614-600-2113

Pennsylvania

City: Pittsburgh RECRUITING
Facility: University of Pittsburgh Medical Center
Contact Info:
boozs@upmc.edu 412-864-7516

Washington

City: Seattle RECRUITING
Facility: Benaroya Research Institute at Virginia Mason
Contact Info:
mariaalicia.reyes@commonspirit.org (206)-341-1450

City: Seattle RECRUITING
Facility: University of Washington - Fred Hutchinson
Contact Info:
foerstb@uw.edu (206) 685-1179

Puerto Rico

City: Rio Piedras RECRUITING
Facility: Hospital Oncologico - Puerto Rico Medical Center
Contact Info:
ramon.vega@panoncologytrials.com 787-407-3333

Other Countries

Country: Denmark
City: Copenhagen RECRUITING
Facility: Copenhagen University Hospital
Contact Info:
john.gasdal.karstensen@regionh.dk

Country: Germany
City: Bonn RECRUITING
Facility: Universitätsklinikum Bonn
Contact Info:
robert.hueneburg@ukbonn.de

Country: Netherlands
City: Amsterdam RECRUITING
Facility: Amsterdam UMC
Contact Info:
e.dekker@amsterdamumc.nl

Country: Netherlands
City: Nijmegen RECRUITING
Facility: Radboud University Medical Center
Contact Info:
tanya.bisseling@radboudumc.nl

Country: Spain
City: Barcelona RECRUITING
Facility: Hospital Clínic de Barcelona
Contact Info:
fprunes@clinic.cat

Country: Spain
City: Valencia RECRUITING
Facility: Hospital La Fe de Valencia
Contact Info:
bustamante_mar@gva.es

Prevention

Prevention study for people with Familial Adenomatous Polyposis (FAP) who have polyps in the colon or rectum

Clinicaltrials.gov identifier:
NCT06950385

Study Contact Information:

Name: Amy Ellenberger
Phone Number: 210-346-8330
Email: aellenberger@lumabridge.com

PRINTER FRIENDLY PAGE